Company Analysis

Sarepta Therapeutics, Inc. (SRPT)

Nasdaq: SRPT · Pharmaceutical Preparations · Cambridge, MA · filing with the SEC since 1997
Grade6.2
◀ Past 8.0● Present 5.6▶ Future 5.0
1 est.

Income statement, as filed

In thousands of US dollars (USD), as filed; per-share figures in US dollars; share counts in thousands. The fiscal year ends in December.
Income statement, by fiscal year, newest first
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period endingDec 31, 2025Dec 31, 2024Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019Dec 31, 2018Dec 31, 2017Dec 31, 2016
Report filedMar 2, 2026Feb 28, 2025Feb 28, 2024Feb 28, 2023Mar 1, 2022Mar 1, 2021Feb 26, 2020Feb 28, 2019Mar 1, 2018Feb 28, 2017
Revenue2,198,2371,901,9791,243,336933,013701,887540,099380,833301,034154,5845,421
Cost of revenue25,500········130
Research and development1,522,066804,522877,387877,090771,182722,343560,909401,843166,707188,272
Selling, general and administrative491,716557,872481,871451,421282,660317,875284,812207,761122,68283,749
Total costs and expenses2,898,0181,683,8981,511,1601,469,2141,161,5971,104,2621,086,396644,662326,222272,151
Operating income-699,781218,081-267,824-536,201-459,710-564,163-705,563-343,628-171,638-266,730
Interest expense-38,140-18,391-22,010r-53,248r63,52559,94730,66933,7095,801r1,892
Interest and investment income30,76330,63536,25716,4883542,9707,2386,8101,809507
Share of profit of equity-method investments00-30,321-2,575······
Other income (expense), net-19,30642,69333,055-28,321-61,238r517-236-656601r930r
Total non-operating income (expense)-2,44442,693-252,274-153,76240,76211,098-8,317-18,982123,010-535
Income before income taxes-702,225260,774-520,098-689,963-418,948-553,065-713,880-362,610-48,628-267,265
Income tax expense11,18525,53515,87913,525-1681,0631,195-6922,060·
Net income including non-controlling interests-713,410235,239-535,977-703,488-418,780-554,128-715,075-361,918-50,688-267,265
Net income-713,410235,239-535,977-703,488-418,780-554,128-715,075-361,918-50,688-267,265
Net income to common shareholders-713,410235,239-535,977·······
Earnings per share, basic-7.132.47-5.80-8.03-5.15-7.11····
Earnings per share, diluted-7.132.34-5.80-8.03-5.15-7.11····
Earnings per share, basic and diluted····-5.15-7.11-9.71-5.46-0.86-5.49
Weighted average shares, basic100,12095,07592,39887,55981,26277,95673,61566,25058,81848,697
Weighted average shares, diluted100,120107,87592,39887,55981,26277,95673,61566,25058,818·
Weighted average shares, basic and diluted····81,26277,95673,61566,25058,81848,697
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.Share counts and per-share figures are on the newest report's basis, after the 1-for-6 reverse split of Jul 2012.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Revenue what customers paid for what it soldus-gaap:Revenues
Cost of revenue what it cost to make or buy what it soldus-gaap:CostOfRevenue
us-gaap:CostOfGoodsSold
Research and development spent on inventing what it sells nextus-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
us-gaap:ResearchAndDevelopmentExpense
Selling, general and administrative the cost of selling and of running the companyus-gaap:SellingGeneralAndAdministrativeExpense
Total costs and expenses every operating cost, the cost of revenue includedus-gaap:CostsAndExpenses
Operating income profit from running the business, before interest and taxus-gaap:OperatingIncomeLoss
Interest expense what its borrowing costus-gaap:InterestExpense
Interest and investment income what its cash and investments earnedus-gaap:InvestmentIncomeInterest
Share of profit of equity-method investments its share of companies it partly ownsus-gaap:IncomeLossFromEquityMethodInvestments
Other income (expense), net gains and costs outside the businessus-gaap:OtherNonoperatingIncomeExpense
Total non-operating income (expense) everything outside the business, togetherus-gaap:NonoperatingIncomeExpense
Income before income taxes profit before taxus-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
Income tax expense tax charged on the period's profitus-gaap:IncomeTaxExpenseBenefit
Net income including non-controlling interests the whole group's profit, minority holders' share includedus-gaap:ProfitLoss
Net income the profit or loss that belongs to the company's shareholdersus-gaap:NetIncomeLoss
Net income to common shareholders what is left for common shareholdersus-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
Earnings per share, basic net income per share outstandingus-gaap:EarningsPerShareBasic
Earnings per share, diluted net income per share, counting every share that could be issuedus-gaap:EarningsPerShareDiluted
Earnings per share, basic and diluted net income per share, where both counts are the sameus-gaap:EarningsPerShareBasicAndDiluted
Weighted average shares, basic the average count of shares outstandingus-gaap:WeightedAverageNumberOfSharesOutstandingBasic
Weighted average shares, diluted the average count with every share that could be issuedus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Weighted average shares, basic and diluted the average count, where both counts are the sameus-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
SI Assistanton SRPT · research, not advice